Showing results (401-410 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|December 28, 2019
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort studyKasiani C Myers, Elissa Furutani, Edie Weller, et al.
The Lancet. Haematology|March 19, 2018
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trialJennifer R Brown, Mehdi Hamadani, John Hayslip, et al.
The Lancet. Haematology|March 24, 2017
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysisRick Admiraal, Stefan Nierkens, Moniek A de Witte, et al.
The Lancet. Haematology|November 16, 2016
Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trialRakesh Popat, Sarah R Brown, Louise Flanagan, et al.
The Lancet. Haematology|October 18, 2016
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysisImke H Bartelink, Arief Lalmohamed, Elisabeth M L van Reij, et al.
The Lancet. Haematology|December 5, 2016
Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 studyRichard R Furman, Herbert A Eradat, Christine G DiRienzo, et al.
The Lancet. Haematology|April 3, 2019
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)Franck Morschhauser, Ian W Flinn, Ranjana Advani, et al.
The Lancet. Haematology|March 18, 2019
Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trialJavier Bolaños-Meade, Kenneth R Cooke, Christopher J Gamper, et al.
The Lancet. Haematology|March 4, 2019
Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trialCatriona Parker, Shekhar Krishnan, Lina Hamadeh, et al.
The Lancet. Haematology|April 16, 2017
Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort studyTorben B Larsen, Flemming Skjøth, Jette N Kjældgaard, et al.
Pageof 73